🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and immunogenicity of high-titered ALVAC-HIV MN120TM...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000847
Treatments Being Tested
The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, i...
Status
Completed
Location
Walter Reed Army Institute of Research
Start Date
1998-04
Trial ID
NCT00004579
Treatments Being Tested
To evaluate the safety and immunogenicity of ALVAC-HIV MN120TMG (vCP205) in...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00001055
Treatments Being Tested
The purpose of this study is to find out whether three different anti-HIV v...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000904
To evaluate the safety and immunogenicity of an accelerated schedule of rec...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00001076
Treatments Being Tested
The purpose of this study is to test three experimental HIV vaccines. This ...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000946
To evaluate the safety and immunogenicity of live recombinant canarypox ALV...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00001090
Treatments Being Tested
The purpose of this study is to determine the best way to administer the ca...
Status
Unknown
Location
Walter Reed Army Institute of Research (WRAIR)
Start Date
TBD
Trial ID
NCT00013572
Treatments Being Tested
The purpose of this study is to see if it is safe to give ALVAC-HIV vCP205,...
Status
Completed
Location
UVRI - IAVI HIV Vaccine Program
Start Date
TBD
Trial ID
NCT00007423
Treatments Being Tested
The purpose of this study is to see if it is safe to give an HIV vaccine (v...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00001136
Treatments Being Tested